MHY553
MHY553 has been studied in 2 papers since 2017: none in people yet, 2 in animals. The research so far is in animals. The newest paper, Nov 13, 2020: “2,4-Dihydroxyphenyl-benzo[d]thiazole (MHY553), a synthetic PPARα agonist, decreases age-associated inflammatory responses through PPARα activation and RS scavenging in the skin”.
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Pusan National University
- Animals2
What did studies of MHY553 find?
9Studies of MHY553 measured 9 outcomes, among them PPARA, pro-inflammatory cytokine expression and MAPK/AP-1 signaling.
PPARA
upin rats1
1 study
PPARA
upin rats1
MHY553 activates PPARA in rats (aged rat skin and H2O2-induced Hs27 fibroblasts).
“inhibits inflammatory cytokines through PPARα activation in the skin”
Animalsaged rat skin and H2O2-induced Hs27 fibroblastsskin
Experimental gerontology
Pro-inflammatory cytokine expression
downin rats1
1 study
Pro-inflammatory cytokine expression
downin rats1
MHY553 decreases pro-inflammatory cytokine expression in rats (aged rats).
“MHY553 also inhibited the expression of pro-inflammatory cytokines including COX-2, iNOS, IL-1β, and IL-6”
Animalsaged ratsskin3 mg or 5 mg/kg/day4 weeks
Experimental gerontology
MAPK/AP-1 signaling
downin rats1
1 study
MAPK/AP-1 signaling
downin rats1
MHY553 inhibits MAPK/AP-1 signaling in rats (aged rats).
“downregulated mitogen-activated protein kinase (MAPK)/activator protein-1 (AP-1) signaling”
Animalsaged ratsskin3 mg or 5 mg/kg/day4 weeks
Experimental gerontology
NF-κB signaling
downin rats1
1 study
NF-κB signaling
downin rats1
MHY553 inhibits NF-κB signaling in rats (aged rats).
“MHY553 suppressed the NF-κB transcription factor”
Animalsaged ratsskin3 mg or 5 mg/kg/day4 weeks
Experimental gerontology
Reactive oxygen species
downin cells1
1 study
Reactive oxygen species
downin cells1
MHY553 decreases reactive oxygen species in cells (dose-dependent).
“MHY553 dose-dependently scavenged ROS and ONOO−”
Cells
Experimental gerontology
Fatty acid β-oxidation
upin rats1
1 study
Fatty acid β-oxidation
upin rats1
MHY553 increases fatty acid β-oxidation in rats.
“increased mRNA levels of its downstream genes related to fatty acid oxidation, including CPT-1A and ACOX1”
Animals
Oncotarget
Inflammation
downin rats1
1 study
Inflammation
downin rats1
MHY553 decreases inflammation in rats.
“Furthermore, MHY553 significantly suppresses inflammatory mRNA expression in old rats.”
Animalsliver
Oncotarget
Body weight
no changein rats1
1 study
Body weight
no changein rats1
MHY553 showed no clear effect on body weight in rats.
“without changes in body weight and serum levels of liver injury markers.”
Animals
Oncotarget
Hepatic steatosis
downin rats1
1 study
Hepatic steatosis
downin rats1
MHY553 decreases hepatic steatosis in rats.
“When administered orally, MHY553 markedly ameliorated aging-induced hepatic steatosis without changes in body weight and serum levels of liver injury markers.”
Animalsliver
Oncotarget